Clinical trial · Observational
PET-guided Radiotherapy for Patients With Small Cell Lung Cancer.
Prospective PET-guided Radiotherapy for Patients With Small Cell Lung Cancer.
NCT06247163CI-TRIAL-00081124PET-ARTrecruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
There is a prospective risk-adapted evaluation of the optimal dose of radiotherapy for definitive radiotherapy of locally advanced small cell lung cancer within the corridor recommended as standard therapy according to the current interdisciplinary S3 guideline of the German Cancer Society/Cancer Aid/AWMF
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Small Cell Lung Carcinoma | Lung Small Cell Carcinoma | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| PET based Raditherapy boost | Radiation | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (3)
- measure
- Local recurrence free survival
- timeFrame
- 2 months to 5 years
- description
- Local recurrence free survival
- measure
- Distant recurrence free survival
- timeFrame
- 2 months to 5 years
- description
- Distant recurrence free survival
- measure
- Overall survival
- timeFrame
- 2 months to 5 years
- description
- Overall survival
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Histopathologic confirmation * Limited disease Exclusion Criteria: * Other histology than small cell lung cancer * Further tumor diagnosis * ECOG 3 or worse * Extensive disease * stage IV
References
Publications (0)
Data not yet available
No reference posted for this study.